Provided by Tiger Trade Technology Pte. Ltd.

Regeneron Pharmaceuticals

797.94
+3.750.47%
Volume:184.75K
Turnover:146.47M
Market Cap:82.15B
PE:19.73
High:799.51
Open:782.44
Low:779.08
Close:794.19
52wk High:847.00
52wk Low:541.00
Shares:102.95M
Float Shares:98.88M
Volume Ratio:0.41
T/O Rate:0.19%
Dividend:3.64
Dividend Rate:0.46%
EPS(TTM):40.43
EPS(LYR):41.48
ROE:14.04%
ROA:6.53%
PB:2.59
PE(LYR):19.24

Loading ...

Jan 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 28, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 14, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 12, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 06, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 08, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 02, 2023

Major Issues Report

Form 8-K - Current report
Nov 02, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 13, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 06, 2023

Major Issues Report

Form 8-K - Current report
Oct 03, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 03, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 28, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Sep 09, 2023

Major Issues Report

Form 8-K - Current report
Sep 08, 2023

Major Issues Report

Form 8-K/A - Current report: [Amend]